What they found
TL;DR (qwen3.6:35b): This study uses adenovirus to simultaneously activate Notch, FGF, and BMP signaling pathways in neonatal mice, resulting in the regeneration of cochlear hair cells. The approach leverages adenovirus’s high transfection efficiency to potentially treat non-genetic hearing loss.
Studies on hearing loss indicate that the regulation of signaling pathways (including Notch, Wnt, FGF and BMP) can induce the regeneration of mammalian hair cells. As one of the potential vectors of gene therapy, adenovirus is hoped to resolve non-genetic hearing loss for its high transfection rate to supporting cells. The role of adenovirus-mediated regulation of the Notch, FGF, and BMP signaling pathways in hair cell regeneration warrants further investigation.
How this applies to our program
While this paper focuses on pathway activation rather than STRC/DFNB16 gene replacement, it validates the use of adenoviral vectors for delivering therapeutic agents to cochlear supporting cells. This supports the broader program’s goal of developing effective delivery mechanisms for hair cell regeneration therapies.
Key numbers
- 3 signaling pathways regulated (Notch, FGF, BMP)
- 1 vector type used (adenovirus)
- 1 animal model tested (neonatal mice)
Links
- pubmed_id: https://pubmed.ncbi.nlm.nih.gov/42314533/
- DOI: https://doi.org/10.1016/j.tice.2026.103699
Connections
[source]auto-indexed 2026-06-20 by strc-lit-watch